Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.

Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q35745390
Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisThe Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.Revisiting the biological roles of PAI2 (SERPINB2) in cancer.Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues.Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma.Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas.Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.Association between expression of nuclear receptor co-activator 5 protein and prognosis in postoperative patients with osteosarcoma.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860

Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q35745390
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@ast
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@en
type
label
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@ast
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@en
prefLabel
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@ast
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Cellular distribution and clin ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P304
P31
P356
10.1016/S0002-9440(10)64761-X
P407
P433
P478
P577
P5875
P698
P932